This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
STORAGE/SUPPLY AND HANDLING from THE TREMFYA PRESCRIBING INFORMATION
- The company cannot recommend any practices, procedures, usage, or storage conditions that deviate from the product labeling.
- TREMFYA is a clear and colorless to light yellow solution.1
- TREMFYA is supplied as a single-dose, sterile, preservative-free solution for subcutaneous injection.1
- Store in a refrigerator between 36ºF to 46ºF (2ºC to 8ºC).1
- Store in the original carton until time of use.1
- Protect from light until use.1
- Do not shake.1
- Do not freeze.1
TEMPERATURE EXCURSION
- TREMFYA prefilled syringes (100 mg/mL and 200 mg/2 mL), prefilled pens
(100 mg/mL and 200 mg/2 mL), and the One-Press patient-controlled injector
(100 mg/mL) may be exposed 1 time only to temperatures above 46º F (8º C) and not exceeding 86º F (30º C) for no more than 4 hours under standard room lighting (not excess lighting) in preparation for administration by patients and healthcare professionals.2
1 | Data on File. Guselkumab Company Core Data Sheet (CCDS) v22. Janssen Research & Development, LLC. EDMS-ERI-111962822; 2025. |
2 | Data on File. Guselkumab Technical Document Memo: DS-TEC-112372. Janssen Biotech, Inc.; 2019. |